Analyst Ranking
Bottom 2%
#4958 out of 5014 analysts
Average Return
-39.41%
Win Rate
8%2 out of 24
Risk vs Reward
Poor
Good

Steven Mah's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Omniab IncOABI
+39.49%$3.95$5.51
2023-02-22 -
2024-02-21
Buy
Biolife Solutions IncBLFS
+5.81%$24.11$25.51
2024-11-13 -
2025-09-12
Strong Buy

Steven Mah Analyst Color

Get additional color on Steven Mah's coverage of popular stocks

Steven Mah's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Twist Bioscience CorpTWST
3Strong Buy$58.00+129.16%Reiterates
10 months ago
Biolife Solutions IncBLFS
2Strong Buy$31.00+21.52%Maintains
10 months ago
Ginkgo Bioworks Holdings IncDNA
2Buy$120.00N/AMaintains
2 years ago
Schrodinger IncSDGR
1Buy$42.00N/AInitiates Coverage On
2 years ago
Phenomex IncCELL
1Hold$1.00N/ADowngrades
2 years ago
Omniab IncOABI
1Buy$10.00N/AInitiates Coverage On
3 years ago
23andme Holding CoMEHCQ
1Buy$120.00N/AInitiates Coverage On
3 years ago
Absci CorpABSI
1BuyN/AN/AUpgrades
3 years ago
Codexis IncCDXS
2Buy$21.00N/AMaintains
3 years ago
Talis Biomedical CorpTLIS
2Hold$135.00N/ADowngrades
4 years ago
Heska CorpHSKA
2Strong Buy$305.00N/AMaintains
4 years ago
Natera IncNTRA
2Strong Buy$155.00N/AMaintains
4 years ago
Akoya Biosciences IncAKYA
1Strong Buy$28.00N/AInitiates Coverage On
4 years ago
Luminex CorpLMNX
1Hold$37.00N/ADowngrades
4 years ago
Fulgent Genetics IncFLGT
1Strong Buy$140.00N/AMaintains
5 years ago
Ortho Clinical Diagnostics Holdings PLCOCDX
1Strong Buy$27.00N/AInitiates Coverage On
5 years ago
Pacific Biosciences Of California IncPACB
1Strong Buy$52.00N/AUpgrades
5 years ago
Oxford Immunotec Global PLCOXFD
1Hold$22.00N/ADowngrades
5 years ago
Insight Molecular Diagnostics IncIMDX
1Strong Buy$80.00N/AUpgrades
5 years ago
Illumina IncILMN
1Hold$340.00N/ADowngrades
5 years ago
Quidelortho CorpQDEL
1Strong Buy$250.00N/AMaintains
5 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.